IBDEI0LK ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10222,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,10222,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,10223,0)
 ;;=190.1^^44^562^83
 ;;^UTILITY(U,$J,358.3,10223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10223,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10223,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,10223,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,10224,0)
 ;;=190.2^^44^562^50
 ;;^UTILITY(U,$J,358.3,10224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10224,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10224,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,10224,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,10225,0)
 ;;=190.7^^44^562^52
 ;;^UTILITY(U,$J,358.3,10225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10225,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10225,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,10225,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,10226,0)
 ;;=202.81^^44^562^61
 ;;^UTILITY(U,$J,358.3,10226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10226,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,10226,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,10226,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,10227,0)
 ;;=215.9^^44^562^85
 ;;^UTILITY(U,$J,358.3,10227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10227,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,10227,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,10227,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,10228,0)
 ;;=224.2^^44^562^51
 ;;^UTILITY(U,$J,358.3,10228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10228,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10228,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,10228,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,10229,0)
 ;;=224.5^^44^562^96
 ;;^UTILITY(U,$J,358.3,10229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10229,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10229,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,10229,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,10230,0)
 ;;=224.7^^44^562^28
 ;;^UTILITY(U,$J,358.3,10230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10230,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10230,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,10230,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,10231,0)
 ;;=237.70^^44^562^66
 ;;^UTILITY(U,$J,358.3,10231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10231,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,10231,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,10231,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,10232,0)
 ;;=239.6^^44^562^65
 ;;^UTILITY(U,$J,358.3,10232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10232,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10232,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,10232,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,10233,0)
 ;;=239.81^^44^562^97
 ;;^UTILITY(U,$J,358.3,10233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10233,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10233,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,10233,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,10234,0)
 ;;=272.0^^44^562^48
 ;;^UTILITY(U,$J,358.3,10234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10234,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,10234,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,10234,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,10235,0)
 ;;=340.^^44^562^63
 ;;^UTILITY(U,$J,358.3,10235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10235,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,10235,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,10235,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,10236,0)
 ;;=345.90^^44^562^29
 ;;
 ;;$END ROU IBDEI0LK
